A Palm Beach physician-scientist is leading efforts to create breakthrough treatments for Parkinson’s, ALS, Alzheimer’s and other diseases through a biotech company she established nearly a decade ago.
Dr. Simrit Parmar, a Northwestern University-trained oncologist and research scientist, launched Cellenkos Inc., in 2016 to accelerate the clinical development of “T regulatory cell” therapies for the treatment of autoimmune diseases and inflammatory disorders.
T regulatory cells, or Tregs (pronounced tee-regs), are natural immune system regulator cells that suppress the activity of other immune cells to prevent excessive inflammation and autoimmune reactions…